Loading provider…
Loading provider…
Radiation Oncology Physician in Berlin, VT
NPI: 1043443518Primary Practice Location
Central Vermont Medical Center
130 Fisher Rd, Berlin, Vermont, 05602
HQ Phone
Mobile
Get MD Carl's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
VT State Medical License
Rutgers New Jersey Medical School
njms.rutgers.edu
Medical School
Until 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99213Established patient office or other outpatient visit, typically 15 minutes | 96 | 117 |
| 2 | 77334Design and construction of complex radiation treatment device | 72 | 191 |
| 3 | 77427Radiation treatment management, 5 treatment sessions | 69 | 195 |
| 4 | 77263Complex radiation therapy planning | 67 | 71 |
| 5 | 77300Calculation of radiation therapy dose | 60 | 164 |
Racial Disparities in Hypofractionated Radiotherapy Breast Cancer Clinical Trials.
Authors: Sharad Goyal, Nadine Housri, Neil Taunk, Bruce Haffty, Atif Khan
Journal: Breast J
Publication Date: 2015-04-27
Active Surveillance for Medically Inoperable Stage IA Lung Cancer in the Elderly.
Authors: Hyunsoo No, Havaleh Gagne, Nikoletta Sidiropoulos, Garth Garrison, Nataniel Lester-Coll, Steven Lin, Christopher Anker
Journal: Cureus
Publication Date: 2018-10-22
Authors: Alan Homans, Alissa Thomas, Suzanne Tucker, Susan Durham
Journal: Pediatr Blood Cancer
Publication Date: 2018-09-25
Lead Sponsor: Canadian Cancer Trials Group
Collaborators: NRG Oncology, SWOG Cancer Research Network, Eastern Cooperative Oncology Group, Alliance for Clinical Trials in Oncology
Intervention / Treatment: RADIATION: Radiation, OTHER: No Radiation
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI), Canadian Cancer Trials Group
Intervention / Treatment: OTHER: Questionnaire Administration, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, RADIATION: Radiation Therapy, RADIATION: Hypofractionated Radiation Therapy
Lead Sponsor: NRG Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Questionnaire Administration, DRUG: Temozolomide, OTHER: Laboratory Biomarker Analysis, OTHER: Quality-of-Life Assessment, RADIATION: Intensity-Modulated Radiation Therapy, RADIATION: 3-Dimensional Conformal Radiation Therapy, RADIATION: Proton Beam Radiation Therapy, RADIATION: Photon Beam Radiation Therapy